EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 298 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $14,889,000 | -11.7% | 342,494 | +1.7% | 0.15% | -11.1% |
| Q3 2021 | $16,857,000 | -22.0% | 336,680 | -1.9% | 0.17% | -21.9% |
| Q2 2021 | $21,610,000 | -57.0% | 343,055 | -36.5% | 0.22% | -59.2% |
| Q1 2021 | $50,229,000 | -14.8% | 540,620 | -17.8% | 0.54% | -22.2% |
| Q4 2020 | $58,935,000 | +112.0% | 657,766 | +144.5% | 0.69% | +78.3% |
| Q3 2020 | $27,801,000 | +79.5% | 269,057 | +37.3% | 0.39% | +74.3% |
| Q2 2020 | $15,491,000 | +3.0% | 195,896 | -24.6% | 0.22% | -13.6% |
| Q1 2020 | $15,041,000 | -26.3% | 259,955 | -31.3% | 0.26% | +0.8% |
| Q4 2019 | $20,415,000 | -42.4% | 378,416 | -44.2% | 0.26% | -46.2% |
| Q3 2019 | $35,426,000 | +28.3% | 677,628 | +18.6% | 0.47% | +29.5% |
| Q2 2019 | $27,605,000 | +3.6% | 571,409 | +8.3% | 0.37% | +2.5% |
| Q1 2019 | $26,644,000 | – | 527,400 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |